Ayoade Joy Ademuyewo founded Lokum last year to create a solution to better connecting medical specialists with health care facilities nationwide. Photo courtesy of Lokum

A Houston health care innovator is celebrating an oversubscribed round of pre-seed funding to improve on her startup's unique staffing platform.

Ayoade Joy Ademuyewo founded Lokum last year to create a solution to better connecting medical specialists with health care facilities nationwide. The new platform, which cuts out the middleman and lowers staffing costs, raised $700,000 in pre-seed funding that will go toward further development of the technology.

"Healthcare organizations spend $26 billion annually to support a crippling dependence on third-party agencies for connecting with clinical staff," Ademuyewo says in a news release. "Technological solutions that are pointed precisely to streamline and strengthen the relationships between highly specialized clinicians and their future employers are vital to alleviating this detrimental dependance, and central to our mission.

"I'm incredibly proud to have earned the trust of my colleagues, investors, team, and mentors in solving this complex problem."

Ademuyewo raised the round with support from local investors, including Aileen Allen, an adviser and investor associated with the Houston Angel Network, Mercury, and The Artemis Fund; and Matt Miller, former Liongard product executive, as well as from Houston-based VC firm South Loop Ventures. Techstars and JP Morgan also contributed to the round.

"Lokum has found a way to disrupt an organically inefficient and expensive market with an elegant solution that doesn't just save hospitals time and money, but also increases the pool of specialty providers in a market that is consistently strapped for such expertise," Jerry Varnado, venture partner at South Loop Ventures, adds. "This is what disruption in healthcare looks like — scalable commercial solutions that contribute towards better patient care, and we're happy to be part of Lokum's journey."

Ademuyewo has the idea to start Lokum after her experience as an independent contract nurse anesthetist amid the height of the pandemic as she witnessed third-party recruitment agencies take advantage of medical professionals like herself.

Now, the platform's early pilot, which focuses on clinicians in anesthesiology, has served clients across nearly 200 hospitals and surgery centers in 20 states. Ademuyewo also participated in 2024’s cohort for the Google for Startups Accelerator Program-North America, where she spent 10 weeks developing and building her company and platform.

Houston Community College and its partner received funding that will go toward creating a certificate program that will launch in the fall 2022 semester as part of The Resilient Workforce Collaborative. Photo via HCC

Houston college system snags part of $3.3M investment in resiliency innovation

impact investment

Houston Community College and partners received a $1.8 million grant from JP Morgan Chase this month with the goal of training underserved Houstonians in jobs that will help boost the city's preparedness for the aftermath of natural disasters.

The funds will go toward creating a certificate program that will launch in the fall 2022 semester as part of The Resilient Workforce Collaborative.

“The Resilient Workforce Collaborative brings together the public sector, private sector, higher education institutions, and our nonprofit partners to make transformational change in our most underserved neighborhoods,” Mayor Sylvester Turner says in a statement. “The collaborative complements our efforts within the Complete Communities to prepare low-to-moderate income Houstonians for high-demand jobs and increase the diversity of candidates in the talent pipelines for green careers that will advance our city’s resilience. This resourceful partnership is a welcomed addition to Houston’s workforce development landscape.”

The collaborative will operate out of HCC's Resiliency Center of Excellence, which was first announced in May and is slated to open its $35 million Resiliency Operations Center at HCC's Northeast College in 2024. Other members of the collaborative include City of Houston, Harris County, Workforce Solutions Gulf Coast, Resilience Innovation Hub, American Youth Works, WorkTexas, TRIO Electric, TRIO Education, Memorial Assistance Ministries, South Union CDC, Impact Hub Houston, Neuhaus Education Center, TXRX Labs, Volunteers of America-TX, Wesley Community Center, and JPMorgan Chase.

The program will aim to help residents who come from some of Houston’s most underserved and under-resourced neighborhoods find career opportunities in the clean energy, disaster response, utilities, trades and manufacturing fields. According to HCC, "an important element of the collaborative is employers changing some of their hiring practices to emphasize specialized training certificates over traditional 4-year degrees."

So far, partnering employers include The City of Houston, Harris County and TRIO Electric—and the collaborative is looking for more employers and funders to support its mission.

“This collaborative provides a ‘go-to place’ for Houstonians to learn skills that will lead to good paying jobs. It is a better system because it’s set up to fulfill needs that already exist in the workplace,” HCC Chancellor Cesar Maldonado said in a statement.

HCC and the City of Houston signed a memorandum of understanding in August, on the five-year anniversary of Hurricane Harvey, that the organizations would train 500,000 citizens, employees, small businesses, volunteers, and first responders in new resiliency training programs starting this fall.

At the time, seven courses in resiliency were announced, with an additional 30 courses slated to be added in 2023. The program will be offered at 22 HCC locations.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.